{
  "ptid_time": "068_S_4174_2011-08-19",
  "img_path": "/data/qiuhui/data/adni/images/068_S_4174/2011-08-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 13,582 mm³, 51.6% below the reference mean. With a Z-score of -1.18 (11.9th percentile), this represents mild atrophy; hippocampal volume measures 8,240 mm³, 15.8% above the reference mean. With a Z-score of 1.45 (92.7th percentile), this represents mild enlargement; whole brain volume measures 1,036,760 mm³, 6.4% above the reference mean. With a Z-score of 0.80 (78.9th percentile), this represents normal volume ; entorhinal cortex volume measures 3,409 mm³, 7.2% below the reference mean. With a Z-score of -0.44 (33.0th percentile), this represents normal volume ; fusiform gyrus volume measures 18,139 mm³, 6.6% above the reference mean. With a Z-score of 0.60 (72.7th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,473 mm³, 6.8% above the reference mean. With a Z-score of 0.59 (72.3th percentile), this represents normal volume . ",
  "text_data": "Age is 73.7 years. Gender is Female. Education: 18 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Malignancy; Major Surgical Procedures. MMSE: 29.0. MoCA: 30.0. Logical Memory: 12.0. Laboratory findings: . APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.50 SUVR (profound elevated); Amyloid beta: 734.60 pg/mL (normal ); Total tau: 260.90 pg/mL (normal ); Phosphorylated tau: 26.77 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild ventricular atrophy but otherwise normal or above-average volumes in key regions (hippocampus, whole brain, fusiform gyrus, middle temporal gyrus). Cognitive scores (MMSE 29, MoCA 30) are intact, and CSF biomarkers (Aβ, T-tau, P-tau) are normal despite elevated AV45 (amyloid PET), which may suggest early amyloid accumulation without downstream neurodegeneration.  \n\n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (AV45 elevation is concerning for preclinical amyloid pathology, but structural and cognitive measures remain normal, making progression uncertain at this stage.)",
  "timestamp": "2025-07-26T08:59:58.427834"
}